Viable: yes, no, or somewhere in the middle?

Viability testing plays a key role in the treatment of patients with ischemic cardiomyopathy. We have long known that, for patients with coronary artery disease, having decreased left ventricular function carries an increased risk of mortality, hospital stay, arrhythmia, and decreased quality of